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Abstract
Significance: Mechanosignaling is vital for maintaining the structural integrity of bone under physiologic con-
ditions. These signals activate and suppress multiple signaling cascades regulating bone formation and re-
sorption. Understanding these pathways is of prime importance to exploit their therapeutic potential in
disorders associated with bone loss due to disuse, trauma, or disruption of homeostatic mechanisms. Recent
Advances: In the case of cells of the bone, an impressive amount of data has been generated that provides
evidence of a complex mechanism by which mechanical signals can maintain or disrupt cellular homeostasis by
driving transcriptional regulation of growth factors, matrix proteins and inflammatory mediators in health and
inflammation. Mechanical signals act on cells in a magnitude dependent manner to induce bone deposition or
resorption. During health, physiological levels of these signals are essential for maintaining bone strength and
architecture, whereas during inflammation, similar signals can curb inflammation by suppressing the nuclear
factor kappa B (NF-jB) signaling cascade, while upregulating matrix synthesis via mothers against dec-
apentaplegic homolog and/or Wnt signaling cascades. Contrarily, excessive mechanical forces can induce in-
flammation via activation of the NF-jB signaling cascade. Critical Issues: Given the osteogenic potential of
mechanical signals, it is imperative to exploit their therapeutic efficacy for the treatment of bone disorders. Here
we review select signaling pathways and mediators stimulated by mechanical signals to modulate the strength
and integrity of the bone. Future Directions: Understanding the mechanisms of mechanotransduction and its
effects on bone lay the groundwork for development of nonpharmacologic mechanostimulatory approaches for
osteodegenerative diseases and optimal bone health. Antioxid. Redox Signal. 20, 970–985.
Introduction
Mechanical signals regulate diverse cellular processes,including cell proliferation, metabolism, homeostasis,
differentiation, immune responses, and cell damage through
control of anabolic and catabolic activities (75). Bone is an
inherently dynamic tissue capable of recognizing and adapt-
ing to external forces to meet its functional demands. It re-
sponds to the external mechanical forces in the environment
by dynamic remodeling of its mass and architecture via bone
resorption, synthesis, and apposition (8, 38). The importance
of mechanical load is further underscored by the observations
that reduced physical demands or disuse of bones leads to
rapid bone loss and skeletal fragility and osteopenia generally
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observed in aging, spinal cord injuries, prolonged bed rest,
and microgravity (9, 84, 86, 89, 120, 122). Conversely, physi-
ological loading of the skeleton is anabolic and stimulates
osteogenesis; hence, acting as an important therapeutic signal
in diseases associated with inflammation, osteopenia, osteo-
porosis, and arthritis (8, 85, 107, 120, 121). Clinically, it is well
documented that appropriate exercise is beneficial not only
for arthritic diseases of the joints involving cartilage and bone
damage, but also for systemic diseases, such as systemic
lupus erythematous and diabetes (76, 109). However, exces-
sive mechanical forces or overload are detrimental and initiate
bone pathologies. These observations provide ample evidence
that mechanical forces are critical determinants in regulating
gene expression, protein synthesis, cell function, and overall
skeletal integrity (1, 57, 82). All of these studies point to the fact
that bone tissue has mechanosensing networks that direct
growth and remodeling; therefore, understanding the molec-
ular mechanisms by which mechanical stimuli on the bone are
sensed and translated to biochemical responses is relevant to
human health and disease.
Mechanical forces applied to the bone cause deformation.
In the bone these are in the form of strain and shear. Strain is a
dimensionless unit formally defined as the change in length
divided by its original length (e =DL/L). Shear stress arises
from the interstitial fluid flow through the bone canalicular
system and is expressed as force of flow per unit area. While
the range of physiological levels of dynamic strain that are
osteogenic still remain vague, it is well established that static
strain suppresses bone formation (18, 87). Both the magnitude
and frequency of mechanical forces are important for bone
formation. Being a mineralized tissue, bone perceives rela-
tively low strains (500 le or 0.05%) at frequencies of 1–3Hz
during normal activity (6, 23, 40, 92). In the long bones of
humans and animals, these strains have been observed to
increase up to 0.2%–0.35% during vigorous activities (6, 12,
91). Strains of *0.7% or greater have been shown to be
traumatic and lead to bone damage (13, 116, 133). It is now
well established that bone cells respond to changes in com-
pressive, tensile, or shear stresses applied by the external
mechanical environment. However, because of the complex-
ity of the simultaneous exposure of these forces on the cells,
how these forces affect cellular physiology and metabolism
disparately is as yet unclear (43, 93, 98). In recent years, sev-
eral in vivo and in vitro systems have been developed to better
understand the responses of bone cells to mechanical forces.
Many aspects of mechanosignaling have been elegantly re-
viewed in recent years (6, 8, 30, 38, 42, 67, 72, 74, 86, 91, 106,
122). The goal of the present review is to elaborate on the
major intracellular mechanisms of mechanotransduction that
regulate bone homeostasis, bone pathologies, and attenuation
of inflammation using in vitro and in vivo models.
Mechanosensitive Cells in Bone
Mechanical forces perceived by bone are translated into
biochemical signals that are then integrated into cellular
FIG. 1. Cells of the BMU. (A) Saggital section of bone showing locations of mature osteocytes, osteoclasts and osteoblasts
shown in (B–E). (B) Cross-section of cortical bone (cb) showing an osteon of the Haversian system. Each osteon contains
concentric layers of lamellae that surround the central Haversian canal (hc). Osteocytes (oc) are located in the lacunar space (ln)
and are connected by an extensive network of canaliculi (cn). The cytoplasmic processes of osteocytes located in the canaliculi
perceive mechanical signals and respond to them. (C) Enlarged micrograph of osteon showing osteocytes in the lacunar space
and interconnected canaliculi. (D) Amultinucleated osteoclast (ocl) juxtaposed to trabecular bone (tb), showing bone resorption.
Bone marrow (bm) is shown around the trabeculae. (E) Sagittal section at junction of cortical bone and bone marrow showing a
layer of osteoblast-like lining cells (ob) depositing osteoid (os) at the endocortical region of the bone. BMU, bone multicellular
unit. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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responses via mechanotransduction (39). Bone adapts to me-
chanical stimuli via the extensively interconnected networks
of cells in the bone multicellular unit (BMU) (63, 100). The key
cellular components of the BMU are osteocytes, osteoblasts,
and osteoclasts (Fig. 1A–E). Osteoblasts and osteocytes are
mesenchymal cells that differentiate from stem cells residing
in the bone marrow, while osteoclasts originate from mono-
cytes of the hematopoietic cell lineage. Osteocytes reside in
cortical (or compact) and trabecular (or spongy) bone matrix
(Fig. 1A–C), whereas osteoclasts (Fig. 1D) and osteoblasts
(Fig. 1E) occupy the bone marrow lining the bones in their
active state. During bone remodeling, a process driven by
mechanical loads, mature bone is resorbed by osteoclasts and
new bone is deposited by osteoblasts to meet the mechanical
demands. The osteocytes, osteoblasts, and osteoclasts are
interconnected via intricate cellular networks designed to
perceive and transmit mechanical stimuli and facilitate com-
munication between cells within the bone. All of these cells are
shown to perceive and respond to mechanical signals in vitro
(82, 93). In vivo, osteocytes heavily populating cortical and
trabecular bone have long dendritic processes that intercon-
nect neighboring osteoblasts via functional gap junctions and
hemichannels. While osteocytes are regarded as the initiator
of the bone remodeling process, the collective mechan-
osensitivity of osteocytes, osteoblasts and osteoclasts appear
to be essential for bone remodeling (42, 90). For example, in-
tercellular communication between osteocytes and osteo-
blasts is essential for the induction of alkaline phosphatase
(ALKP) and activation of extracellular signal regulated kinase
1/2 (ERK1/2), both of which are required for bone forma-
tion/remodeling (3, 114).
Mechanosensors on cells
The components of the BMU function as a large mechan-
osensitive organ by bridging the physical forces and bio-
chemical signals through activation or inhibition of receptors
on the cell surface and within the signaling pathways. Evi-
dence thus far strongly suggests that integrins and focal ad-
hesions are the ubiquitous receptors of mechanical forces
capable of detecting alterations in the mechanical environ-
ment in the extracellular milieu. Heterodimers of a and b
subunits of integrins (a5b1) in osteocytes and osteoblasts
connect their cytoskeleton to the extracellular matrix (ECM)
via arginine-glycine-aspartic acid sequences in fibronectin
(Fig. 2A) (112). The sensing of mechanical signals by integrins
FIG. 2. Mechanosensors FAK and integrins. (A) Schematic representation of heterodimers of alpha and beta subunits of
integrin connecting the ECM to cytoskeleton via binding to fibronectin. After perception of mechanical signals, integrins
attach to actin, recruiting paxillin, talin, and vinculin in the focal adhesions and transmit the force to the cytoskeleton. This
requires FAK phosphorylation and PYK2 and Src activation. The integrins and focal adhesion complexes lead to activation of
RAS/Raf and MAPKs, resulting in ERK1/2 and p38 activation with subsequent transcription of Jun/fos and bone associated
transcription factors. Integrin activation also induces NF-jB activation, leading to COX2 production required for osteoblast
proliferation. (B) Mechanosome pathway of integrin-mediated mechanotransduction showing that shear stress triggers ac-
tivation of NOS, sGC and PKGII complex via NO production and cGMP-mediated activation of PKGII, respectively. This
leads to phosphorylation of SHP-1 and subsequent activation of Src, which is required for the activation of the MEK pathway
activating ERK1/2. ERK is known to activate osteoblast proliferation and differentiation via transcription of fos and other
osteogenic genes. The wide (yellow in online version) arrows indicate the known steps affected by mechanosignaling in the
integrin and FAK signaling cascades. cGMP, cyclic guanosine monophosphate; COX2, cyclooxygenase 2; ECM, extracellular
matrix; ERK1/2, extracellular signal regulated kinase 1/2; FAK, focal adhesion kinase; MAPK, mitogen activated protein
kinases; MEK, mitogen activated protein kinase kinase; NF-jB, nuclear factor kappa B; NO, nitric oxide; NOS, nitric oxide
synthase; PKGII, protein kinase GII; sGC, soluble guanylyl cyclase; SHP-1, small heterodimer partner-1. To see this illus-
tration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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transmits force through focal adhesions and intracellular
stress fibers of F-actin, talin, vinculin, p130Cas, and paxillin
(41, 99). When associated with talin and paxillin in focal ad-
hesions, integrins bind to focal adhesion kinase (FAK). FAK
also mediates bone regeneration in adult mice and osteo-
blastic responses to oscillatory fluid shear stress. Furthermore,
the absence of FAK function compromises multiple responses
to fluid flow, such as ERK1/2 activation, as well as expression
of c-Fos, cyclooxygenase 2 (COX2) and osteopontin (OPN)
that are required for osteoblast proliferation (46, 130).
Rangaswami et al. have suggested an alternate ‘‘mechano-
some pathway’’ of mechanotransduction that is mediated by
integrin b3 (80). In this pathway, fluid shear stress from in-
terstitial fluid flow triggers assembly of small heterodimer
partner-1 (SHP-1) and SHP-2 with b3 integrins that contain
adhesion complexes capable of initiating gene expression and
cell proliferation. In this process, nitric oxide synthase (NOS)
leads to activation of soluble guanylyl cyclase (sGC) and
protein kinase GII (PKGII) via cyclic guanosine monopho-
sphate (cGMP). This activation phosphorylates SHP-1, Src
and subsequently mitogen activated protein kinase kinase
(MEK) (Fig. 2B). These findings further confirm the role of
integrins and FAK in mechanosignaling. Other molecules,
such as E-cadherins, calcium (Ca ++ ) channels, connexin 43,
and ion channels are also shown to mediate signals generated
by shear/compressive strain (5, 51, 73, 78).
Mechanotransduction in healthy bones
Mechanotransduction initiates diverse signaling cascades
that collectively regulate functions of various bone cell types.
Cells exposed to mechanical strain experience combinations
of shear, compressive and tensile forces. Both in vivo and
in vitro systems have been used to study mechanotransduc-
tion; in vitro studies have utilized primary cultures of osteo-
cytes, osteoblasts, osteoblast-like cells, and osteoclasts in
monolayers and 3D scaffolds, while in vivo studies employ
experimental animal models (22, 66, 68, 122). It is as yet un-
clear howmechanosignals perceived by the candidate sensors
b-integrin/FAK complexes trigger a vast variety of signaling
cascades. Nevertheless, evidence thus far indicates that reg-
ulation of bone formation and resorption via mechan-
otransduction is primarily mediated by pathways used by
growth factors and mediators, such as nitric oxide (NO),
prostaglandin E2 (PGE2), Ca
++ , mothers against dec-
apentaplegic homolog (SMAD), b-catenin, nuclear factor
kappa B (NF-jB) and ERK1/2 cascades, rather than a single
‘‘mechanosignaling pathway’’ (39, 44, 74, 75, 97, 98, 116).
Mechanoactivation of these intracellular signaling pathways
converge to activate/inhibit osteogenic transcription factors,
runt-related transcription factor-2 (RUNX-2), Osterix (OSX)
and Msh homeobox-2 (MSX-2), as well as regulators of
growth factors and matrix proteins required for osteodiffer-
entiation (76).
Elements of Mechanosignaling
Nitric oxide
NO induction is a key event during load sensing. It is in-
duced by shear stress and dynamic compression in osteo-
blasts (82, 125, 132). Relatively small magnitudes of dynamic
compression stimulate low levels of inducible NO synthase
FIG. 3. Mechanotransduction in
osteoblasts regulates NO and
BMP production in a magnitude-
dependent manner in vitro. Ef-
fects of various magnitudes of dy-
namic compression on the (A)
production of NO, exhibiting low-
er induction of NO at 10% dynamic
compression and higher induction
at 20%–40%, (B) mRNA expression
for BMP-2, and (C) BMP-4 show-
ing upregulation of both BMP-2
and BMP-4 at 10% dynamic
compression and suppression at
20%–40%. Effects of 10% dynamic
compression on mRNA expression
for (D) BMPs, (E) matrix associated
proteins and (F) bone associated
transcription factors. The data in
(A–F) represent the standard error
of the mean of three separate ex-
periments performed in duplicate.
*Represents p< 0.05. BMP, bone
morphogenetic proteins.
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(iNOS) mRNA expression and synthesis in calvarial cells (82).
Nitrite accumulation in response to various magnitudes of
dynamic compression has revealed that dynamic compres-
sion at relatively low magnitudes (10%) induces low levels of
NO production; however, at higher magnitudes of dynamic
compression (20%–30%) mechanical signals become trau-
matic/proinflammatory and induce high levels of NO. NO
induction at lowmagnitudes ofmechanical strain is paralleled
by induction of osteogenic proteins that drive bone/cartilage
formation, such as bone morphogenetic proteins (BMP)-2
and - 4, while higher magnitudes (20%–30%) inhibit BMP-2
and - 4 expression in osteoblasts and osteoblast-like peri-
odontal ligament cells (Fig. 3A–C) (1, 55, 70). Furthermore,
lower dynamic compression (10%) promotes mRNA expres-
sion for BMPs, matrix associated proteins and osteogenic
transcription factors (Fig. 3D–F) (18, 26, 32, 58). These findings
provide evidence for the force magnitude dependent re-
sponses of bone cells. Similarly, gentle exercise in vivo leads to
the production of BMPs, transcription factors, and matrix-
associated proteins which drive osteogenesis.
Recently, an integral role of NO in osteoblast mechan-
otransduction has also been described (80). The authors
demonstrate that fluid shear stress activates the integrin-Src
containing complex through NO-cGMP-PKGII pathway to
activate the ERK pathway and induction of several genes
(c-fos, fra-1, fra-2, fosB). ERK1/2 activation and induction of
these genes are required for multiple cell functions, such as
adhesion, migration, proliferation, and cell survival (Fig. 2B).
Prostaglandin E2
Mechanical signals are shown to induce transient secretion
of PGE2 as an osteogenic signal (15). This increase in PGE2 is
paralleled by the induction of COX2 (50) that drives PGE2
synthesis. In vivo, loading induces upregulation of PGE2 in
humans and COX2 in rats (21, 117). COX2 inhibitors, such as
nonsteroidal anti-inflammatory drugs (NSAIDs) or NS-398
prevent loading induced bone synthesis, suggesting an im-
portant role for PGE2 in mechanosensitive osteogenesis (21).
Furthermore, fluid flow leads to the expression of prosta-
glandins and ATP through connexin 43 expression on the cell
surface (3). Prostaglandins thus, act on osteoblasts and oste-
oclasts via autocrine and paracrine signaling to provoke os-
teogenic responses to mechanical stimuli (42).
Interestingly, in comparison to wild type COX2+/+ mice,
the null mutation of COX2 (COX2 -/- ) results in reduced
femoral bone mass, altered architecture, and inferior me-
chanical properties. However, the COX2-/- genotype does
not influence the responses of bone to mechanotransduction,
suggesting that a functional COX2 gene may not be required
for mechanical load-induced osteogenesis. COX2 -/- mice
show an increased expression of COX1 in response to me-
chanical loading, likely to compensate for the absence of
COX2 (2).
Ca ++ and ion channels
Ca ++ plays an integral role in osteogenesis. Therefore, it is
not surprising that Ca ++ mobilization is upregulated by me-
chanotransduction. Intracellular Ca ++ is increased in re-
sponse to mechanical loading of osteoblasts that is inhibitable
by gadolinium, a stretch activated ion channel blocker. Ver-
apamil and nifedipine, which block L-type Ca ++ channels,
also suppress loading induced bone formation, further sug-
gesting a role of Ca++ mobilization in mechanotransduction
(51). Influx of Ca ++ has been linked to many mechan-
osensitive signaling pathways, such as NO, protein kinase A,
NF-jB, PGE2, mitogen activated protein kinases (MAPK),
c-fos, and phosphoinositide 3-kinase (116).
SMAD signaling
SMAD signaling plays an important role in bone formation
and is required for induction of bone specific transcription
factors, BMPs and bone matrix proteins (Fig. 4). SMADs are a
family of transcription factors that are regulated by the
members of the transforming growth factor-b (TGF-b) family
of molecules, TGF-b and BMPs. So far eight different SMADs
FIG. 4. SMAD signaling cascade. Mechanoactivation of
murine osteoblasts by dynamic compression and fluid flow
results in SMAD 1/5/8 phosphorylation via association and
activation of BMP receptors. Phosphorylated SMAD 1/5/8
coupled with the regulatory SMAD-4 translocate to the
nucleus and activate osteogenic transcription factors and
proteins, such as RUNX-2, OSX, DLX and BMPs. Simulta-
neously, activation of BMP-receptors activates MAPK,
ERK1/2, p38, and JNK and subsequently their response el-
ements. The wide (yellow in online version) arrows indicate
the known steps utilized by mechanosignaling in the SMAD
and MAPK signaling cascades. DLX, distal-less homeobox;
JNK, c-JUN N-terminal kinases; OSX, osterix; RUNX-2, runt-
related transcription factor-2; SMAD, Mothers against dec-
apentaplegic homolog. To see this illustration in color, the
reader is referred to the web version of this article at
www.liebertpub.com/ars
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have been identified and these work through a myriad of
pathways to regulate bone formation. BMP regulated
SMADs, such as SMADs 1/5/8 that are activated via BMP
binding (to type I and type II receptors) activate BMP target
genes, such as RUNX-2 and OSX that are required for osteo-
genesis. The regulatory SMAD 4 or inhibitory SMADs 6/7
also work via SMAD/1/5/8 by regulating the nuclear trans-
location and gene transcription activity of the activated/
phosphorylated SMAD 1/5/8 complexes. BMP receptor and
SMAD 1/5/8 complexes can also activate theMAPKpathway
to activate genes involved in osteoblast differentiation (4, 71).
In contrast to the BMP activated SMADs, TGF-b regulatory
SMADs, such as SMAD 2/3 work synergistically and antag-
onistically to regulate osteogenesis and when activated by
TGF-b, SMAD3 can inhibit osteocalcin (OCN) expression by
repressing RUNX-2 (45, 104).
Mechanical signals are potent activators of bone formation
via activation of the SMAD signaling cascade. Activation of
murine osteoblasts by dynamic compressive forces or fluid
flow strain results in SMAD 1/5/8 phosphorylation, which
mediates the BMP signaling cascade (48, 81). Furthermore,
treatment of osteoblasts with Dorsomorphin, an inhibitor of
BMP receptor 1 (BMPR1), downregulates dynamic compres-
sion induced SMAD 1/5/8 phosphorylation in osteoblasts,
suggesting that BMPR1 may be activated by mechan-
otransduction (81, 82). Activation of SMAD 1/5/8 by me-
chanical forces is paralleled by the induction of RUNX-2,
BMP2, MSX-2, OSX, as well as bone matrix proteins, such as,
OPN, OCN, ALKP, and Collagen type 1a1 (COL-1a1) in os-
teoblasts (Fig. 3D–F) (82, 128). The observation that inactiva-
tion of RUNX-2 in transgenic mice results in complete lack of
ossification further supports the fact that mechanical signals
have osteogenic potential (47). Not only does fluid flow strain
induce osteogenic transcription factors, but it also synergizes
with BMP-2 to induce expression of BMP-2, - 4 and - 7, as
well as distal-less homeobox (DLX)-4 and DLX-5 homeotic
genes involved in osteogenesis (48). Similar to the direct ef-
fects of mechanical loading on osteoblasts, distraction osteo-
genesis or reconstruction surgery are also shown to induce
SMAD 1/5/8 induction and BMP-2 and - 4 expression in
sheep mandible (20). Similarly, physical activity is also a po-
tent osteogenic signal in vivo, as evident by incorporation of
Ca ++ binding fluorescent dyes in bone and formation of os-
teoid at the endosteal and periosteal sides of long bones (Fig.
5A) (122). This bone formation is paralleled by induction of
BMP-2, - 4, - 7, RUNX-2, ALKP, and OCN in trabecular bone
(Fig. 5B–G) (47, 61, 122).
Wnt (wingless) signaling
Wnt/b-catenin signaling plays a critical role in osteogenic
differentiation and maintenance of bone (49, 77, 124). This
pathway is initiated by Wnt ligands binding to the receptor
complex formed by low-density lipoprotein receptor-related
protein 5 or 6 (Lrp 5/6) and the 7-transmembrane domain
spanning frizzled (Fzd) receptor (16, 34, 37). b-catenin a key
component of this pathway; lies downstream of Wnt, and is
stabilized by Wnt activation. Transduction of Wnt signals
leads to downstream inhibition of cytoplasmic glycogen
synthase kinase 3 (GSK3), effectively preventing proteasomal
degradation of b-catenin. This leaves b-catenin free to accu-
mulate in the cytoplasm and reach levels that promote nuclear
translocation where it regulates gene transcription of osteo-
blastogenic mediators, such as RUNX-2 (24, 28). During
FIG. 5. Mechanical signals generated by gentle exercise up-regulate bone remodeling and expression of osteogenic growth
factors. (A) Sagittal sections of femurs endogenously stained with calcein and alizarin in control and exercised mice (upper
panels), showing bone growth in mouse femur subjected to gentle exercise for 10 days and compared to femur from non-
exercised controls. Lower panels are schematic representations of calcein and alizarin incorporation in the micrographs. Ex-
pression of mRNA for (B) BMP-2, (C) BMP-4, (D) RUNX-2, (E) BMP-7, (F) ALKP, and (G) OCN in rat femurs after 0, 2, or 5 days
of exercise at 12 M/min for 45min/day. Each bar represents five rats. *Represents p< 0.05. ALKP, alkaline phosphatase; OCN,
osteocalcin. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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cellular differentiation, the presence of b-catenin is required to
commit mesenchymal stem cells (MSCs) to an osteoblastic
lineage and to prevent adipogenic or chondrocytic differen-
tiation of MSCs (29, 36). Several antagonists tightly regulate
Wnt signaling in bone. For example, sclerostin (SOST) and
Dickkopf related protein (Dkk) take a major role in inhibiting
Lrp 5/6 activity, whereas secreted frizzled related protein
(Sfrp) and Wnt inhibitory factor-1 (WIF-1) prevent interac-
tions between Wnt and Fzd receptors (Fig. 6) (10, 53, 62, 102,
119). As discussed below several of the key players in theWnt
pathway are regulated by mechanical forces.
Mechanical loading promotes Wnt/b-catenin canonical
signaling in osteoblasts subjected to cyclic strain in vitro and
after tibial loading (35, 83). Loading controls b-catenin levels
by regulating phosphorylation of GSK3, thereby inhibiting
b-catenin degradation and increasing its levels in the cyto-
plasm; thus, driving osteoblastic differentiation (14, 103). The
Wnt signals are reported to be transduced through the Lrp 5/
6 receptor; thus, mutations in this receptor results in a con-
stitutive ‘‘ON’’ signal, leading to a state of high bonemass (10,
55, 69), while loss of function mutations in the Lrp5 receptor
lead to poor mechanical response to loading (70, 101).
Mechanical signals prevent SOST expression in osteocytes,
thereby preventing SOST-induced inhibition of the Wnt sig-
naling pathway (88, 119). SOST is secreted primarily by os-
teocytes and binds to Lrp 5/6, inhibiting the Wnt signaling
pathway and impeding osteoblast proliferation and differ-
entiation (53, 102, 123). The relationship between osteogenesis
and SOST is demonstrated through the loss of function mu-
tations in the Sost gene, which leads to sclerosteosis, a disease
characterized by high bone mass (7, 102). The SOST -/ - mice
are also resistant to mechanical unloading induced bone loss
and exhibit higher bone mass compared to wild type mice
(54). Thus, upregulation of b-catenin and downregulation
of SOST by mechanical signals emphasize the relationship
between osteoblastic activity and mechanical strain (Fig. 6)
(79, 122).
Mechanotransduction in osteoclast formation
and function
Dynamic bone remodeling preserves bone mass and ar-
chitecture through the balanced activity of osteoclasts that
resorb bone and osteoblasts that produce new bone. Thus,
FIG. 6. Mechanical signals up-regulate Wnt signaling to promote bone formation. (A) Binding of Wnt to Fzd and Lrp 5/6
inhibits GSK3 via activation of Frat1, Axin and Dsh. Inactivation of GSK3 allows b-catenin to accumulate in the cytoplasm
and translocate into the nucleus. In the nucleus, the binding of b-catenin to TCF/LEF and transcriptional coactivators allows
transcription of osteoblast specific genes. (B) Inhibitors of Wnt signaling (SOST, Sfrp, Dkk, WIF-1) can block the interactions
of Wnt with Lrp 5/6 and Fzd. Blockage of this complex allows phosphorylation of b-catenin by active GSK3 and stimulates
b-catenin degradation. Mechanical signals inhibit SOST, Sfrp and WIF-1, enabling Wnt to bind to Fzd and Lrp 5/6. This
binding prevents b-catenin degradation, allowing for nuclear translocation and subsequent transcriptional activity. The wide
(yellow in online version) arrows indicate the known steps in mechanotransduction that up or down regulate Wnt signaling
cascades. Dkk, Dickkopf related protein; Dsh, disheveled; Fzd, frizzled; GSK3, glycogen synthase kinase 3; Lrp 5/6, lipo-
protein receptor-related protein 5 or 6; Sfrp, secreted frizzled related protein; SOST, sclerostin; WIF-1, Wnt inhibitory factor-1.
To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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stringently controlled osteoclastic activity is integral in pre-
serving the structural integrity of bone as osteoblasts. Fully
differentiated osteoclasts are multinucleated bone resorptive
cells found on the surfaces of bone. These cells originate from
the hematopoietic (monocyte/macrophage) lineage, but their
differentiation is regulated by a group of factors mainly eli-
cited by osteoblasts and osteocytes. The factors involved
in the differentiation and maturation of osteoclasts are
the receptor activator of NF-jB (RANK/TNFS11), RANK li-
gand (RANKL/TNFRS11A), and osteoprotegerin (OPG/
TNFRS11B). The role of the RANK/RANKL signaling cas-
cade is to regulate bone turnover by stimulating osteo-
clasts differentiation and activation. Binding of soluble or
membrane-bound RANKL to RANK present on the pre-
osteoclast surface triggers lineage commitment and os-
teoclastic differentiation, while continued RANKL/RANK
signaling is required for mature osteoclast function. OPG, a
soluble protein expressed by osteoblasts, as well as many
other cell types, acts as a decoy receptor for RANKL, thereby
inhibiting osteoclast differentiation and activation (11, 105,
115, 118, 126). Binding of RANKL to RANK activates both
canonical and noncanonical NF-jB signaling cascades, which,
along with the transcription factor activator protein-1 (AP-1),
leads to activation of calcinurin dependent NF of activated
T-cells c1 (NFATc1), which is required for terminal differen-
tiation of osteoclasts (Fig. 7) (113).
Mechanical loading was originally shown to inhibit osteo-
clastogenesis, a key step to osteoclast differentiation, in mu-
rine marrow cells in vitro by Rubin et al. (94). Since then,
studies have shown that physiological strain inhibits key
steps during osteoclast differentiation. iNOS and NO that are
increased by fluid flow strain and dynamic compression in-
hibit osteoclast differentiation by upregulating OPG; thus,
decreasing RANKL activity (19, 27, 33, 60). Mechanical strain
(of 2% at 0.16Hz) reduces vitamin 1,25(OH)2D3 - induced
osteoclast formation by 50% in murine bone marrow stromal
cell cultures in vitro. This suppression in osteoclast differen-
tiation is paralleled by a reduction in RANKL expression by
60% as compared to untreated cells (96). These independent
findings suggest that mechanical signals may induce OPG
and suppress RANKL to collectively inhibit osteoclast dif-
ferentiation (Fig. 7). Cyclic stretch at 10% elongation and
0.5Hz also reduces the total number of differentiated osteo-
clasts, nuclei/cell and expression of osteoclast-specific genes
tartrate-resistant acid phosphatase (TRAP), matrix metallo-
proteinases (MMP)-9, cathepsin-K, and calcitonin receptors in
murine RAW 264.7 preosteoclasts (111).
Mechanotransduction in response to trauma
Deformation of bone above strains of 0.7% could cause
traumatic bone damage (13, 116). Acute or chronic cartilage/
bone injuries (sterile or nonsterile) can cause bone trauma and
is considered to be a major etiological factor for initiation of
diseases like osteoarthritis (31, 129). Mechanosensitive oste-
oblasts and osteoblast-like cells perceive trauma as an external
insult. It is as yet unclear how bone cells perceive and dif-
ferentiate responses to two drastically opposite magnitudes of
mechanical signals, that is, those of physiological magnitudes
that initiate regenerative responses and of traumatic signals
that initiate bone damage and resorption. Knowledge re-
garding the receptors involved in relaying traumatic signals
from the extracellular surface of the bone cells to the intra-
cellular milieu also remains unclear. Traumatic signals are
perceived by all bone cells and initiate proinflammatory sig-
naling cascades via activation of NF-jB transcription factors.
NF-jB activation leads to the production of high levels of NO
and superoxide that mediate both bone damage and matrix
degradation. Additionally, elaboration of proinflammatory
FIG. 7. Mechanical signals suppress osteoclast differen-
tiation. The RANK-RANKL signaling cascade controls dif-
ferentiation and activation of osteoclasts. RANKL, bound to
osteoblast membranes or as soluble RANKL, binds to and
activates RANK. RANK-RANKL binding stimulates activa-
tion of TRAF6 to activate NF-jB and NFAT transcription
factors. TRAF activation also activates the MAPK cascade.
NF-jB, NFAT and MAPKs are required for osteoclast dif-
ferentiation and activation. A competitive inhibitor of
RANKL, OPG, prevents osteoclast differentiation by block-
ing RANKL binding to RANK. Mechanical signals suppress
RANKL expression, as well as upregulate OPG expression;
thus, inhibiting the initial step in osteoclast differentiation
and activation. Mechanical signals, shown to suppress
NF-jB activation, may also prevent osteoclast activation. The
wide (yellow in online version) arrows indicate the known
steps in mechanotransduction that up or down regulate
RANK-RANKL signaling cascades. NFAT, NF of activated
T-cells; OPG, osteoprotegerin; RANK, receptor activator of
NF-jB; RANKL, RANK ligand. To see this illustration in
color, the reader is referred to the web version of this article
at www.liebertpub.com/ars
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mediators, such as tumor necrosis factor alpha (TNF-a),
interleukin-1 beta (IL-1b) and MMPs plays a key role in the
pathogenesis of inflammatory bone diseases and injuries (1,
31, 57, 108). These proinflammatory mediators amplify in-
flammation and perpetuate tissue damage. Concurrently, the
inhibition of growth factors and matrix synthesis by inflam-
mation further exacerbates tissue damage (17, 58, 129).
Disuse or reduced loading of bone inhibits osteoblast-
mediated bone formation and accelerates osteoclast-mediated
bone resorption. This leads to a coarse trabecular pattern and
thinning of cortical bone. Bone loss in disuse is accompanied
by NF-jB activation that promotes RANKL production by
osteoblasts and neighboring immune cells to trigger osteoclast
differentiation and activation (131). Collectively, these pro-
cesses result in tissue breakdown and loss of bone matrix and
structure (Fig. 7).
Mechanotransduction and repair in inflammation
Mechanotransduction at low magnitudes is a potent anti-
inflammatory signal. Inflammation activates multiple path-
ways to counter cellular insults; mechanical signals also uti-
lize similar pathways, particularly the NF-jB signaling
cascade, to resolve inflammation. In fact, mechanotransduc-
tion, while dampening inflammatory signaling cascades to
suppress cytokine production, simultaneously restores the
synthesis of BMPs and ECM proteins to repair the damaged
tissue.
In general, trauma, infections, injury, and many bone dis-
eases involve some degree of inflammation. Inflammatory
stimuli sensed by cells activate the rapid response NF-jB
signaling cascade that controls transcription of over 150 target
genes, making it one of the central mediators of inflammation
and immune response (26). Both NF-jB signaling pathways,
canonical and noncanonical, are activated by signals associ-
ated with stress, growth factors, cytokines and inflammatory
mediators (44). The canonical NF-jB signaling cascade in-
volves activation of multiple intracellular adaptor proteins,
including myeloid differentiation primary response gene 88
(MYD88), TIR-domain-containing adapter-inducing interferon-b
(TRIF), TAK, TAB, and TRAF6. Phosphorylated TRAF6
triggers NF-jB activation via IjB kinase complex (IKK),
FIG. 8. Physiologic levels of mechanical signaling inhibit the NF-jB signaling cascade. Inflammatory molecules such
IL-1 or LPS in vitro and inflammatory mediators in vivo activate their respective receptors to initiate a chain of activation and
deactivation of signaling and adaptive proteins, leading to phosphorylation of TRAFs. TRAFs activate IKK that activates IjBa
and IjBb, leading to IjB proteasomal degradation and subsequent nuclear translocation of NF-jB. NF-jB in the cytoplasm is
sequestered by IjBa and IjBb. IKK induced phosphorylation and degradation of IjB allows NF-jB nuclear translocation.
Subsequently, NF-jB binds to the promoters of a plethora of proinflammatory cytokines and mediators to initiate inflam-
mation. Mechanical signals suppress TRAF-6 activation, leading to IKK and IjB inactivation, with subsequent inhibition of
NF-jB nuclear translocation and suppression of proinflammatory gene induction. Simultaneously, inflammation inhibits
matrix synthesis. Mechanical signals counteract this blockage of matrix synthesis and upregulate expression of growth factors
and matrix associated genes. Inset. Effects of 10% dynamic compression on IL-1 induced mRNA expression of salient
proinflammatory and matrix associated genes, showing that 10% dynamic compression suppresses proinflammatory gene
(NOS2, IL-1, TNF-a, MMP13) induction and upregulates matrix associated gene expression (Col-IaI, OCN, ALKP, BMP-6,
BMP-2) suppressed by inflammation. *Represents p < 0.05. The wide (yellow in online version) arrows indicate the
known steps in mechanotransduction that up or down regulate NF-jB signaling cascades and matrix synthesis. IjB, inhibitor
of NF-jB; IKK, IjB kinase complex; IL-1, interleukin-1; LPS, lipopolysaccharide; MMP, matrix metalloproteinases; TNF-a,
tumor necrosis factor alpha. To see this illustration in color, the reader is referred to the web version of this article at
www.liebertpub.com/ars
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comprised of IKKa and IKKb catalytic units and the IKKc
regulatory unit. In the cytoplasm, inactive NF-jB is seques-
tered by the inhibitor of NF-jB (IjB). Upon activation, the IKK
complex phosphorylates IjBa and IjBb proteins on specific
serine residues that promote its proteasomal degradation. The
free NF-jB then translocates to the nucleus and initiates
NF-jB dependent gene transcription capable of eliciting
inflammation, innate immune responses, adaptive immune
responses and osteoclastogenesis (Fig. 8) (25, 44, 110).
Mechanical signals (tensile, compressive, and shear) of low
magnitudes are powerful anti-inflammatory signals that
suppress expression of several proinflammatory moieties,
such as IL-1b induced NOS2, NO, COX2, PGE2, cytokines (IL-
1b and TNF-a), and MMPs in osteoblasts and osteoblasts like
periodontal ligament cells in vitro. Simultaneously, these sig-
nals upregulate the expression of growth factors COL-1a1,
BMPs, OCN and ALKP that are inhibited during inflamma-
tion (inset in Fig. 8) (1, 57). Several anti-inflammatory cyto-
kines (IL-10) and tissue inhibitors of metalloproteinases
(TIMPs) that are inhibited during inflammation are upregu-
lated by mechanical signals. For instance IL-10 and TIMP-II
synthesized by low magnitudes of mechanical signals can
suppress inflammation and matrix breakdown in osteoblast
and osteoblast-like cells (1, 56, 127).
Investigations focused on the mechanisms of mechan-
otransduction in IL-1b treated osteoblast-like cells have
shown that mechanical signals dramatically inhibit NF-jB
nuclear translocation within the initial 10min of the signal to
inhibit proinflammatory gene induction (1). At present, it is
unclear at what stage mechanotransduction intercepts the
NF-jB signaling cascade within osteoblasts. However,
similar studies in chondrocytes have revealed that mechan-
otransduction inhibits TRAF6 phosphorylation and subse-
quent activation of the IKK complex that in turn fails to
phosphorylate IjBa and IjBb and their eventual proteasomal
degradation. This consequently inhibits nuclear translocation
of NF-jB and its binding to consensus sequences and subse-
quent transcriptional activity (Fig. 8) (17, 59, 64, 127). Since the
NF-jB pathway is ubiquitously present in all mammalian
cells, it is activated bymore than 150 different ligands/signals
and follows the same sequential activation, making it likely
that mechanotransduction in osteoblasts follows the same
events as those observed in chondrocytes.
Mechanical signals are shown to inhibit osteoclast dif-
ferentiation and maturation via suppression of RANKL ex-
pression and induction of OPG by osteoblasts in vitro (95,
116). Bone resorption in osteoclasts is heightened during
inflammation through NF-jB activation and induction of
FIG. 9. Signals generated by gentle exercise suppress bone damage in osteoarthritic lesions. (A) Histological sections
showing (a) control distal femoral head with intact bone structures, and (b) bone damage induced by MIA lesions at distal
femoral condyles of rat knees on day 21 post-MIA induction. Black arrows indicate formation of massive bone degradation
and fibrocartilage formation. (c) MIA afflicted rat knees exposed to exercise (12m/min for 45min/day) after MIA induction
showing minimal bone damage and normal histology. Lower panels showing lCT analysis of bone in (d) control with no bone
damage, and (e) extensive bone damage on the femoral head of MIA afflicted knees. White arrows indicate bone lesions. (f)
Minimal bone damage on the femoral head of bone exposed to MIA but exercised daily for 21 days. (B, C) Effects of exercise
on MIA induced mRNA expression of NOS2 and TNF-a in control bones, those exposed to MIA only for 5 and 9 days and
those exposed to MIA and exercise simultaneously for 5 and 9 days, showing their significant down-regulation by exercise.
*Represents p < 0.05. lCT, micro computerized tomography; MIA, monoiodoacetate-induced osteoarthritis. To see this il-
lustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
MECHANOSIGNALING IN BONE 979
RANKL (Fig. 7). Hence, suppression of NF-jB activity in os-
teoblasts by mechanical signals may also suppress osteoclast
differentiation.
Chronic systemic or local inflammatory disorders are in-
variably associated with bone loss. These observations have
prompted investigations to examine the anti-inflammatory
effects of mechanical loading in experimental models of knee
osteoarthritis (32, 66). According to these investigations, ex-
ercise effectively suppresses inflammation of cartilage and
bone. In an experimental model of monoiodoacetate-induced
osteoarthritis (MIA) of rat knees, progression of cartilage
degradation is paralleled by bone loss and its replacement by
inflammatory cells and fibrocartilagenous tissue. However,
inflammation and bone loss induced by MIA is markedly
prevented by gentle treadmill walking (used as exercise) (Fig.
9). The inhibition of bone loss by exercise corresponds with
inhibition of NOS2 and TNF-a mRNA expression in the tra-
becular bone in comparison to bones showing successive
progression of MIA. The inhibition of the progression of MIA
in response to exercise demonstrates the potential of me-
chanosignaling in preferentially targeting theNF-jB signaling
cascade to suppress catabolic activities in inflamed tissue
(65, 66).
Conclusions
This review illustrates the multifaceted aspects of me-
chanotransduction initiated signaling in maintenance of bone
structure and function. The magnitude of mechanical force is
a critical determinant of the outcomes of mechanotransduc-
tion (Fig. 10). In healthy bones, mechanotransduction induced
by physiologic magnitudes of mechanical forces is anabolic
and interacts with cellular signaling networks collectively for
optimal deposition and strengthening of bone. At higher
magnitudes of mechanical forces, mechanotransduction is
directed towards activation of NF-jB signaling cascade and
FIG. 10. A schematic representation of the actions of mechanical signals on the regulation of distinct signaling pathways
in health and inflammation. In healthy bones, physiological levels of mechanical signals act as anabolic signals, and promote
bone formation via activation of the SMAD 1/5/8 signaling pathway that is required for the induction of BMPs, osteogenic
transcription factors (RUNX-2) and proteins necessary for bone formation (ALKP, COL-IaI, OCN). Simultaneously, me-
chanotransduction suppresses SOST induction to allow bone formation via the Wnt signaling pathway. During inflammation,
physiological levels of mechanical signals suppress the NF-jB signaling cascade to block expression of NO, cytokines and
MMPs, and inhibit catabolic actions of proinflammatory mediators. Simultaneously, mechanical signals upregulate the
synthesis of osteogenic molecules that are suppressed during inflammation to initiate repair. The wide (yellow in online
version) arrows indicate the known steps that up or down regulate mechanosignaling in response to various magnitudes of
strains. COL-1a1, collagen type 1a1. To see this illustration in color, the reader is referred to the web version of this article at
www.liebertpub.com/ars
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proinflammatory responses. In inflamed bone, mechan-
otransduction targeted pathways are completely distinct from
homeostatic pathways and are focused towards dampening
the inflammation and abrogating the repression of growth
factors and matrix synthesis caused by inflammation. How-
ever, the magnitude of mechanical signals is only one of the
many factors that are important to the regulation of multiple
signaling cascades that impact bone remodeling. The cellular
responses of bone are also influenced by the number of
loading cycles per unit of time, frequency and the dynamic
versus static nature of the strain. The bone agemay also dictate
the mechanotransduction pathways regulated by mechanical
signals in young versus aging skeleton. Nevertheless, under-
standing of bone mechanotransduction is important for
exploiting its potential to develop new strategies for bone
tissue engineering. It is also important to develop mechanical
stimulation regimens to combat inflammation at the site of
bone damage and create the right environment for bone repair
and homeostasis. These initial findings may also provide a
foundation for future development of nonpharmacologic
treatments of osteodegenerative diseases and maintenance of
bone health during the lifetime.
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Abbreviations Used
lCT¼micro computerized tomography
ALKP¼ alkaline phosphatase
AP-1¼ activator protein-1
BMP¼ bone morphogenetic proteins
BMPR1¼BMP receptor 1
BMU¼ bone multicellular unit
Ca++ ¼ calcium
cGMP¼ cyclic guanosine monophosphate
COL-1a1¼ collagen type 1a1
COX2¼ cyclooxygenase 2
Dkk¼Dickkopf related protein
DLX¼distal-less homeobox
Dsh¼dishevelled
ECM¼ extracellular matrix
ERK1/2¼ extracellular signal regulated kinase 1/2
FAK¼ focal adhesion kinase
Fzd¼ frizzled
GSK3¼ glycogen synthase kinase 3
IKK¼ IjB kinase complex
IL-1b¼ interleukin-1 beta
iNOS¼ inducible NOS
IjB¼ inhibitor of NF-jB
JNK¼ c-JUN N-terminal kinases
LPS¼ lipopolysaccharide
Lrp 5/6¼ lipoprotein receptor-related protein 5 or 6
MAPK¼mitogen activated protein kinases
MEK¼mitogen activated protein kinase kinase
MIA¼monoiodoacetate-induced osteoarthritis
MMP¼matrix metalloproteinases
MSC¼mesenchymal stem cells
MSX-2¼Msh homeobox-2
MYD88¼myeloid differentiation primary response
gene 88
NFATc1¼NF of activated T-cells c1
NF-jB¼nuclear factor kappa B
NO¼nitric oxide
NOS¼nitric oxide synthase
NSAIDs¼nonsteroidal anti-inflammatory drugs
OCN¼ osteocalcin
OPG¼ osteoprotegerin
OPN¼ osteopontin
OSX¼ osterix
PGE2¼prostaglandin E2
PKGII¼protein kinase GII
RANK¼ receptor activator of NF-jB
RANKL¼RANK ligand
RUNX-2¼ runt-related transcription factor-2
Sfrp¼ secreted frizzled related protein
sGC¼ soluble guanylyl cyclase
SHP-1¼ small heterodimer partner-1
SMAD¼mothers against decapentaplegic homolog
SOST¼ sclerostin
TGF-b¼ transforming growth factor-b
TIMPs¼ tissue inhibitor of metalloproteinases
TNF-a¼ tumor necrosis factor alpha
TRAP¼ tartrate-resistant acid phosphatase
TRIF¼TIR-domain-containing adapter-inducing
interferon-b
WIF-1¼Wnt inhibitory factor-1
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